Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Sunshine Biopharma (SBFM) Return on Equity: 2012-2025

Historic Return on Equity for Sunshine Biopharma (SBFM) over the last 8 years, with Sep 2025 value amounting to -0.24%.

  • Sunshine Biopharma's Return on Equity fell 7.00% to -0.24% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.24%, marking a year-over-year decrease of 7.00%. This contributed to the annual value of -0.23% for FY2024, which is 2.00% down from last year.
  • Sunshine Biopharma's Return on Equity amounted to -0.24% in Q3 2025, which was up 7.83% from -0.26% recorded in Q2 2025.
  • Sunshine Biopharma's 5-year Return on Equity high stood at 25.85% for Q4 2021, and its period low was -1.33% during Q1 2023.
  • In the last 3 years, Sunshine Biopharma's Return on Equity had a median value of -0.22% in 2025 and averaged -0.50%.
  • As far as peak fluctuations go, Sunshine Biopharma's Return on Equity soared by 879bps in 2021, and later slumped by 2,671bps in 2022.
  • Sunshine Biopharma's Return on Equity (Quarterly) stood at 25.85% in 2021, then tumbled by 2,671bps to -0.86% in 2022, then soared by 65bps to -0.21% in 2023, then remained steady at -0.21% in 2024, then dropped by 7bps to -0.24% in 2025.
  • Its last three reported values are -0.24% in Q3 2025, -0.26% for Q2 2025, and -0.22% during Q1 2025.